Japan Institute for Health Security National Kohnodai Medical Center

Chiba, Ichikawa 272-8516

2 studies enrolling now · 4 studies all time

What they study most

Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension, Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis (MASH), Schizophrenia

Studies at this site

• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis — Recruiting now
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study — Stopped early
• Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1) — Completed